Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807861
INFERIOR GASTROINTESTINAL TRACT TUMORS (COLON/RECTUM/ANUS)
1949
POSTER PRESENTATION

Intratumoral genetic heterogeneity (ITGH) as a biomarker for NCRT in LARC: CNAS and SVS do not impact LARC outcomes and ITGH estimation

Vandeclécio Lira da Silva
,
Ramon Torreglosa do Carmo
,
Franciele Hinterholz Knebel
,
Fabiana Bettoni
,
Guilherme Pagin São-Julião
,
Bruna Vailati
,
Natalia Mariana Felicio
,
Leonardo Corbi
,
Angelita Habr Gama
,
Anamaria A. Camargo
,
Cibele Masotti
,
Rodrigo Perez


Publication History

Article published online:
06 May 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

Bibliographical Record
Vandeclécio Lira da Silva, Ramon Torreglosa do Carmo, Franciele Hinterholz Knebel, Fabiana Bettoni, Guilherme Pagin São-Julião, Bruna Vailati, Natalia Mariana Felicio, Leonardo Corbi, Angelita Habr Gama, Anamaria A. Camargo, Cibele Masotti, Rodrigo Perez. Intratumoral genetic heterogeneity (ITGH) as a biomarker for NCRT in LARC: CNAS and SVS do not impact LARC outcomes and ITGH estimation. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807861